Bio-IT World
Boston, MA, USA April 15–17, 2024
Advances in Digitalization at the 10th Partner Symposium
March 21, 2024
Automating R&D of Viral and Non-Viral Vectors for Cell and Gene Therapies
Daiichi Sankyo Automates Biological Therapeutics Discovery
March 12, 2024
Developing RNA Therapeutics with Genedata
MorphoSys Accelerates Antibody R&D with Genedata Biologics
Biopharmaceutical Discovery Workflow Platform
Genedata Biologics
Immatics Digitalizes CGT Discovery with Genedata Biologics
Pfizer Builds on the Genedata Biopharma E2E Workflow Platform
Automated Production of Viral Vectors for Cell and Gene Therapy
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
Genedata Biopharma Platform: Digitalizing R&D
Boehringer Ingelheim Expands Genedata to DMPK Operations
November 20, 2023
Automated HT-Engineering Platform for AI-Supported Developability Predictions
Digitalization Fuels Innovation in Vaccine Research
Analyzing Perfusion Processes in an Integrated Process Development Platform
Improving Efficiency in Discovery and Development of Bispecifics and ADCs
Designing and Screening Complex Proteins with Novel Capabilities at Industrial Scale
Design, Generation, and Evaluation for Cancer Immunotherapy
E2E Data Platform to Digitalize & Automate Single-Domain Antibody (sdAbs) R&D
Dragonfly Therapeutics Uses Genedata for Immune Engager R&D
July 13, 2023
Digitalizing Across mAbs, Bispecifics, ADCs
Light Chain Bioscience Chooses Genedata Bioprocess
June 26, 2023
Icosagen Chooses Genedata to Digitalize Recombinant Ab Discovery
December 12, 2022
Streamlining of Large-Molecule Discovery Workflows
Sanofi Expands Usage of Genedata Biologics for HT Antibody Engineering
October 6, 2022
Increasing Efficiency and Quality in Protein, Cell, and Gene Therapeutics
Digitalization of AAV Bioprocess Development
Genedata Wins Swiss Biotech Award
May 3, 2022
Light Chain Bioscience Adopts Genedata Biologics
April 19, 2022
Charles River Licenses Genedata Biologics
February 8, 2022
Ligand Selects Genedata as Antibody Discovery Platform
December 14, 2021
MiNK Adopts Genedata for CGT R&D
December 1, 2021
Streamlining Large-Molecule Discovery Workflows
Industrializing Immuno-Oncology Therapeutic Discovery Platforms
Encoded Accelerates AAV-Based Development
June 30, 2021
7th Annual Genedata Partner Symposium
May 11, 2021
Toward an End-to-End Biologics Repository & Analysis Platform
Biotalys Streamlines Protein-Based Food Protection R&D
March 18, 2021
Teva Takes Data-Driven Decision-Making to Next Level
January 27, 2021
Partnership with IDBS Streamlines Biopharma R&D, Manufacturing
January 12, 2021
Flow Cytometry, Automated Analysis and Reporting
Protein Engineering: Bi- and Multi-Specifics, TCRs, and CAR Ts
Cancer Immunotherapy: TCR-, TCR-Mimetic- and CAR Therapeutics
R&D Automated with Seamless Lab Equipment Integration
July 14, 2020
Data-Driven Decisions to Accelerate Biopharma R&D
Gritstone Oncology Adopts Genedata Biopharma Platform
May 26, 2020
MorphoSys Digitalizes Large-Molecule R&D
Kymab Automates Lab Operations with Genedata
Janssen, Celgene, and Aptevo Streamline Discovery Operations
A Single Source of Truth for Biopharma Discovery Data
A Discovery Platform that Automates Daily Work
Harmonizing & Standardizing Discovery Operations
A Proven Data Backbone for Biopharma Operations
A Constantly Evolving Discovery Platform
A Central Data Infrastructure for Decision-Making
Design, Production, and Analytics of Antibody Drug Conjugates (ADCs)
Agenus Implements Genedata Biologics
December 3, 2019
Immatics Implements Genedata Biologics
November 12, 2019
Manage Developability & Manufacturability Risks of Biologics Molecules
Orion Pharmaceuticals Implements Genedata Biologics
September 11, 2019
Genmab Adopts Genedata Biopharma Platform
July 9, 2019
Bispecific Antibodies: HT Generation, Design, Production, Evaluation
Novel Maturation Process for Generating High-Affinity Antibodies
YBase: A New Integrated Workflow Platform for HT Antibody Discovery
Antibody Engineering Platform: HT Candidate Screening, Optimization
Integrating UCB’s Core Antibody Discovery Process
Industrializing Next-Gen Therapeutic Discovery Platforms
Increasing Throughput: Cell Lines, Non-Antibody Tool Proteins
Biologics Data Platform for Tailored Support of Cell Line Development
Teva Selects Genedata Biologics for Next-Gen R&D
March 21, 2019
New Biotherapeutics R&D Request Management System
February 12, 2019
Biologic Molecule Management for Patent Submissions
Genedata Biopharma Platform: Efficient Large-Molecule R&D
Aptevo Therapeutics Deploys Genedata Biologics
August 20, 2018
Genedata and Boehringer Ingelheim Co-Develop RMS
February 20, 2018
Merck Uses Genedata Biologics for Bispecific Ab Discovery
July 18, 2017
Celebrating 20 Years of Bioinformatics Innovations
May 23, 2017
Genedata Partners with Crescendo Biologics
January 10, 2017
F-star Selects Genedata Biologics
November 15, 2016